Title: Placental Growth Factor Increases Regional Myocardial Blood Flow and Contractile Function in Chronic Myocardial Ischemia
Authors: Liu, Xiaoshun *
Claus, Piet *
Wu, Ming
Reyns, Geert
Verhamme, Peter
Pokreisz, Peter
Vandenwijngaert, Sara
Dubois, Christophe
Vanhaecke, Johan
Verbeken, Erik
Bogaert, Jan
Janssens, Stefan # ×
Issue Date: Mar-2013
Series Title: American journal of physiology. Heart and circulatory physiology vol:304 issue:6 pages:H885-H894
Abstract: Background. Placental growth factor (PlGF) has a distinct biologic phenotype with a predominant proangiogenic role in disease without affecting quiescent vessels in healthy organs. We tested whether systemic administration of recombinant human (rh)PlGF improves regional myocardial blood flow and systolic function recovery in a porcine chronic myocardial ischemia model. Methods. We implanted a flow-limiting stent in the proximal LAD and measured systemic hemodynamics, regional myocardial function using magnetic resonance imaging, and blood flow using colored microspheres 4 weeks later. Animals were then randomized in a blinded way to receive rhPlGF infusion (15µg/kg/day, n=9) or PBS (Control, n=10) for 2 weeks. At 8 weeks, myocardial perfusion and function were re-assessed. Results. Infusion of rhPlGF transiently increased PlGF serum levels more than 30-fold (1153±180 vs 33±19 pg/ml at baseline, p<0.001) without affecting systemic hemodynamics. From 4 to 8 weeks, rhPlGF increased regional myocardial blood flow (MBF) from 0.46±0.11 to 0.85±0.16ml/min/g, with a concommitant increase in systolic wall thickening (SWT) from 11±3% to 26±5% in the ischemic area. In control animals, no significant changes from 4 to 8 weeks were observed (MBF: 0.45±0.07 to 0.49±0.08 ml/min/g and SWT: 14±4% to 18±1%). rhPlGF-induced functional improvement was accompanied by increased myocardial neovascularization, enhanced glycogen utilization, and reduced oxidative stress and cardiomyocyte apoptosis in the ischemic zone. Conclusions. Systemic rhPlGF infusion significantly enhances regional blood flow and contractile function of chronic ischemic myocardium without adverse effects. PlGF protein infusion may represent an attractive therapeutic strategy to increase myocardial perfusion and energetics in chronic ischemic cardiomyopathy.
ISSN: 0363-6135
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Cardiovascular Imaging and Dynamics
Molecular and Vascular Biology
* (joint) first author
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science